<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02596165</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ 2015-327</org_study_id>
    <nct_id>NCT02596165</nct_id>
  </id_info>
  <brief_title>Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics</brief_title>
  <acronym>BR-102</acronym>
  <official_title>Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kantonsspital Liestal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The significance of parameters of the central hemodynamic is based upon their strong&#xD;
      association with left ventricular hypertrophy and target organ damage at the heart.&#xD;
      Noninvasive, auscultatory/ oscillometric and therefore easy applicable measurements of the&#xD;
      central hemodynamic such as presented by the Schiller BR-102 plus PWA device implicate highly&#xD;
      promising potential for research and daily clinical praxis for improved cardiovascular risk&#xD;
      assessment on the population level. The purpose of this study is to evaluate the validity of&#xD;
      the central and peripheral blood pressure and central arterial stiffness measured with the&#xD;
      device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is an open, monocentric cross-sectional research study for the evaluation&#xD;
      of the validity of the central and peripheral blood pressure and central arterial stiffness&#xD;
      measured with the device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland). For&#xD;
      that purpose measurement of the respective parameters in cardiovascular disease free&#xD;
      individuals will be compared with validated devices and the agreement between the devices&#xD;
      will be statistically analyzed. Central blood pressure and central arterial stiffness are&#xD;
      clinically increasingly meaningful parameters of the cardiovascular system that allow&#xD;
      improved, early cardiovascular risk stratification. The significance of parameters of the&#xD;
      central hemodynamic is based upon their strong association with left ventricular hypertrophy&#xD;
      and target organ damage at the heart. Noninvasive, auscultatory/ oscillometric and therefore&#xD;
      easy applicable measurements of the central hemodynamic such as presented by the Schiller&#xD;
      BR-102 plus PWA device implicate highly promising potential for research and daily clinical&#xD;
      praxis for improved cardiovascular risk assessment on the population level.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Stopp because of FDA concrns regarding recruitment.&#xD;
  </why_stopped>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>central blood pressure</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>central arterial stiffness</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peripheral blood pressure</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement peripheral blood pressure with the Schiller BR-102 Plus PWA device</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Aortic Stiffness</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Pulse wave analysis measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse wave analysis measurement with Schiller BR-102 Plus PWA device</intervention_name>
    <description>Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device</description>
    <arm_group_label>Pulse wave analysis measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy individuals free of clinically relevant cardiovascular diseases or diabetes&#xD;
             based on medical history and physical examination.&#xD;
&#xD;
          -  Heart rhythm: Sinus rhythm&#xD;
&#xD;
          -  Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure&#xD;
             (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles)&#xD;
&#xD;
          -  Pacemaker-dependent&#xD;
&#xD;
          -  Pregnancy after the 6th month of the pregnancy&#xD;
&#xD;
          -  Body mass index (BMI)&gt;30 kg/m2&#xD;
&#xD;
          -  Known significant carotid or femoral artery stenosis&#xD;
&#xD;
          -  Impalpable arterial pulse at site of measurement&#xD;
&#xD;
          -  Age under 18 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arno Schmidt-Trucksäss, MD, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department for Sport, Exercise and Health, Sports and Exercise Medicine, University of Basel, Basel, Switzerland, 4052</affiliation>
  </overall_official>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>November 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2015</study_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Arno Schmidt-Trucksäss</investigator_full_name>
    <investigator_title>Professor Dr. Arno Schmidt-Trucksäss</investigator_title>
  </responsible_party>
  <keyword>validation</keyword>
  <keyword>pulse wave analysis</keyword>
  <keyword>blood pressure monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

